GGrantIndex
← Search

Development of Therapeutics for Biodefense and Emerging Infectious Diseases

$3,082,188N01FY2020AINIH

Venatorx Pharmaceuticals, Inc., Malvern PA

Investigators

Abstract

To support the development of therapeutic products effective against resistant bacterial infections.

View original record on NIH RePORTER →